Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-11-15 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $25,000.00 $0
2022-11-08 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $100,000.00 $0
2022-11-01 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $35,000.00 $0
2022-10-27 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $7,500.00 $0
2022-10-14 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $50,000.00 $0
2022-09-30 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $110,000.00 $0
2022-09-23 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $75,000.00 $0
2022-09-16 Rodrigues Dominic Director Purchase · Series D Convertible Preferred Stock +11,416,262 $0.29 $3.3M 11,416,262
2022-09-01 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note +0 $100,000.00 $0
2022-07-27 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $75,000.00 $0
2022-07-15 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $150,000.00 $0
2021-08-16 Raines Heather CFO Grant or award · 8% Unsecured Convertible Promissory Note due 2022 +0 $200,000.00 $0
2021-06-20 Raines Heather CFO Option exercise · 8% Secured Convertible Promissory Notes due 2021 −0 0
2021-06-20 Raines Heather CFO Option exercise · Series D-1 Convertible Preferred Stock +20,289 20,289
2021-06-20 Bailey Webster Director Option exercise · 8% Secured Convertible Promissory Notes due 2021 −0 0
2021-06-20 Bailey Webster Director Option exercise · Series D-1 Convertible Preferred Stock +41,323 41,323
2021-06-20 Pershing Edward Director Option exercise · 8% Secured Convertible Promissory Notes due 2021 −0 0
2021-06-20 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +478,926 478,926
2021-06-20 WACHTER ERIC PHD CTO Option exercise · 8% Secured Convertible Promissory Notes due 2021 −0 0
2021-06-20 WACHTER ERIC PHD CTO Option exercise · Series D-1 Convertible Preferred Stock +1,393,276 1,393,276

Page 12 of 17 · 329 trades